The effect of exogenous GLP-1 on food intake is lost in male truncally vagotomized subjects with pyloroplasty (Q58447745)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23599045%20AND%20SRC:MED&resulttype=core&format=json

29 February 2020

title

The effect of exogenous GLP-1 on food intake is lost in male truncally vagotomized subjects with pyloroplasty (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23599045%20AND%20SRC:MED&resulttype=core&format=json

29 February 2020

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23599045%20AND%20SRC:MED&resulttype=core&format=json

29 February 2020

Carolyn F. Deacon

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23599045%20AND%20SRC:MED&resulttype=core&format=json

29 February 2020

Bolette Hartmann

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23599045%20AND%20SRC:MED&resulttype=core&format=json

29 February 2020

Filip K Knop

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23599045%20AND%20SRC:MED&resulttype=core&format=json

29 February 2020

Jens Juul Holst

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23599045%20AND%20SRC:MED&resulttype=core&format=json

29 February 2020

1

Astrid Plamboeck

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23599045%20AND%20SRC:MED&resulttype=core&format=json

29 February 2020

5

André Wettergren

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23599045%20AND%20SRC:MED&resulttype=core&format=json

29 February 2020

7

Søren Meisner

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23599045%20AND%20SRC:MED&resulttype=core&format=json

29 February 2020

8

Claus Hovendal

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23599045%20AND%20SRC:MED&resulttype=core&format=json

29 February 2020

9

Tina Vilsbøll

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23599045%20AND%20SRC:MED&resulttype=core&format=json

29 February 2020

author name string

Lars B Svendsen

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23599045%20AND%20SRC:MED&resulttype=core&format=json

29 February 2020

publication date

18 April 2013

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23599045%20AND%20SRC:MED&resulttype=core&format=json

American Journal of Physiology - Gastrointestinal and Liver Physiology

29 February 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23599045%20AND%20SRC:MED&resulttype=core&format=json

29 February 2020

volume

304

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23599045%20AND%20SRC:MED&resulttype=core&format=json

29 February 2020

issue

12

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23599045%20AND%20SRC:MED&resulttype=core&format=json

29 February 2020

page(s)

G1117-27

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23599045%20AND%20SRC:MED&resulttype=core&format=json

The inhibitory effects of peripheral administration of peptide YY(3-36) and glucagon-like peptide-1 on food intake are attenuated by ablation of the vagal-brainstem-hypothalamic pathway

29 February 2020

cites work

1 reference

https://api.crossref.org/works/10.1152%2FAJPGI.00035.2013

Sensory nerves contribute to insulin secretion by glucagon-like peptide-1 in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPGI.00035.2013

Do the actions of glucagon-like peptide-1 on gastric emptying, appetite, and food intake involve release of amylin in humans?

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPGI.00035.2013

A safe and noninvasive test for vagal integrity revisited

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPGI.00035.2013

The vagus is inhibitory of the late postprandial insulin secretion in conscious pigs

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPGI.00035.2013

Direct muscarinic cholinergic inhibition of hepatic glucose production in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPGI.00035.2013

Receptor-mediated activation of gastric vagal afferents by glucagon-like peptide-1 in the rat.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPGI.00035.2013

Truncal vagotomy does not affect postabsorptive glucose metabolism in humans.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPGI.00035.2013

Human colon produces fully processed glucagon-like peptide-1 (7-36) amide

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPGI.00035.2013

Preservation of active incretin hormones by inhibition of dipeptidyl peptidase IV suppresses meal-induced incretin secretion in dogs

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPGI.00035.2013

Endogenous glucagon-like peptide-1 slows gastric emptying in healthy subjects, attenuating postprandial glycemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPGI.00035.2013

Effects of glucagon-like peptide-1 and feeding on gastric volumes in diabetes mellitus with cardio-vagal dysfunction.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPGI.00035.2013

Gut hormones, early dumping and resting energy expenditure in patients with good and poor weight loss response after Roux-en-Y gastric bypass.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPGI.00035.2013

Exendin-4 normalized postcibal glycemic excursions in type 1 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPGI.00035.2013

The dipeptidyl peptidase 4 inhibitor vildagliptin does not accentuate glibenclamide-induced hypoglycemia but reduces glucose-induced glucagon-like peptide 1 and gastric inhibitory polypeptide secretion.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPGI.00035.2013

Glucagon-like peptide 1 promotes satiety and suppresses energy intake in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPGI.00035.2013

The effect of physiological levels of glucagon-like peptide-1 on appetite, gastric emptying, energy and substrate metabolism in obesity

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPGI.00035.2013

Determinants of appetite ratings: the role of age, gender, BMI, physical activity, smoking habits, and diet/weight concern

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPGI.00035.2013

Cellular regulation of islet hormone secretion by the incretin hormone glucagon-like peptide 1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPGI.00035.2013

Glucagon-like peptide-1: a potent regulator of food intake in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPGI.00035.2013

Glucagon-like peptide-1-(7-36)amide is transformed to glucagon-like peptide-1-(9-36)amide by dipeptidyl peptidase IV in the capillaries supplying the L cells of the porcine intestine.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPGI.00035.2013

Neural regulation of glucagon-like peptide-1 secretion in pigs

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPGI.00035.2013

The Physiology of Glucagon-like Peptide 1

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPGI.00035.2013

Glucagon-like Peptide 1 (GLP-1): An Intestinal Hormone, Signalling Nutritional Abundance, with an Unusual Therapeutic Potential

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPGI.00035.2013

Mechanisms and clinical efficacy of lixisenatide for the management of type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPGI.00035.2013

Effects of truncal, selective, and highly selective vagotomy on glucose tolerance and insulin secretion in patients with duodenal ulcer. Part II-Comparison of response to oral and intravenous glucose

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPGI.00035.2013

Acute and long-term effects of Roux-en-Y gastric bypass on glucose metabolism in subjects with Type 2 diabetes and normal glucose tolerance.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPGI.00035.2013

Gastric emptying rate and acid secretion after truncal vagotomy and pyloroplasty for duodenal ulceration.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPGI.00035.2013

Gastric emptying: the validity of the paracetamol absorption test adjusted for individual pharmacokinetics

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPGI.00035.2013

Erythromycin antagonizes the deceleration of gastric emptying by glucagon-like peptide 1 and unmasks its insulinotropic effect in healthy subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPGI.00035.2013

Dipeptidyl-peptidase IV hydrolyses gastric inhibitory polypeptide, glucagon-like peptide-1(7-36)amide, peptide histidine methionine and is responsible for their degradation in human serum

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPGI.00035.2013

Distribution of pre-pro-glucagon and glucagon-like peptide-1 receptor messenger RNAs in the rat central nervous system.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPGI.00035.2013

Receptor gene expression of glucagon-like peptide-1, but not glucose-dependent insulinotropic polypeptide, in rat nodose ganglion cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPGI.00035.2013

Rapid tachyphylaxis of the glucagon-like peptide 1-induced deceleration of gastric emptying in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPGI.00035.2013

Normalization of fasting hyperglycaemia by exogenous glucagon-like peptide 1 (7-36 amide) in type 2 (non-insulin-dependent) diabetic patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPGI.00035.2013

Glucagon-like peptide 1 inhibition of gastric emptying outweighs its insulinotropic effects in healthy humans.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPGI.00035.2013

Energy intake and appetite are suppressed by glucagon-like peptide-1 (GLP-1) in obese men

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPGI.00035.2013

Effect of truncated glucagon-like peptide-1 [proglucagon-(78-107) amide] on endocrine secretion from pig pancreas, antrum, and nonantral stomach.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPGI.00035.2013

Tissue and plasma concentrations of amidated and glycine-extended glucagon-like peptide I in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPGI.00035.2013

Mechanisms governing the biphasic pattern of gastric emptying after truncal vagotomy and pyloroplasty

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPGI.00035.2013

Neutral endopeptidase 24.11 and dipeptidyl peptidase IV are both mediators of the degradation of glucagon-like peptide 1 in the anaesthetised pig.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPGI.00035.2013

Role of the vagus nerve in mediating proximal nutrient-induced glucagon-like peptide-1 secretion

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPGI.00035.2013

Intrameal hepatic portal and intraperitoneal infusions of glucagon-like peptide-1 reduce spontaneous meal size in the rat via different mechanisms

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPGI.00035.2013

Endogenous glucagon-like peptide 1 controls endocrine pancreatic secretion and antro-pyloro-duodenal motility in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPGI.00035.2013

Vagal, cholinergic regulation of pancreatic polypeptide secretion

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPGI.00035.2013

Pancreatic-polypeptide response to food in duodenal-ulcer patients before and after vagotomy

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPGI.00035.2013

Cephalic phase of pancreatic-polypeptide secretion studied by sham feeding in man

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPGI.00035.2013

The effect of a high-MUFA, low-glycaemic index diet and a low-fat diet on appetite and glucose metabolism during a 6-month weight maintenance period

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPGI.00035.2013

Peripheral exendin-4 and peptide YY(3-36) synergistically reduce food intake through different mechanisms in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPGI.00035.2013

Exaggerated secretion of glucagon-like peptide-1 (GLP-1) could cause reactive hypoglycaemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPGI.00035.2013

Glucagon-like peptide-1 (GLP-1) receptors expressed on nerve terminals in the portal vein mediate the effects of endogenous GLP-1 on glucose tolerance in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPGI.00035.2013

Truncated GLP-1 (proglucagon 78-107-amide) inhibits gastric and pancreatic functions in man.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPGI.00035.2013

How useful is paracetamol absorption as a marker of gastric emptying? A systematic literature study

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPGI.00035.2013

Effect of 6-week course of glucagon-like peptide 1 on glycaemic control, insulin sensitivity, and beta-cell function in type 2 diabetes: a parallel-group study

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPGI.00035.2013

21 January 2018

Identifiers

DOI

10.1152/AJPGI.00035.2013

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23599045%20AND%20SRC:MED&resulttype=core&format=json

29 February 2020

1 reference